Novo Nordisk’s attempt to create a successor to its weight loss blockbuster Wegovy may have taken a hit with recent ...

Novo Nordisk (NVO) is now offering its GLP-1 weight-loss drug Wegovy direct to ... These are still the pens, which we know is a reason for the ongoing sort of lack of access as these two companies ...

Both Eli Lilly’s Zepbound and Novo Nordisk’s Wegovy cost over $1,300 per month before insurance and other rebates at retail prices. Many consumers have complained that these expensive GLP-1 ...

The two GLP-1 market leaders see the need to launch ... knockoffs sold by compounding pharmacies. Injection pens and boxes of Novo Nordisk's weight-loss drug Wegovy. (Reuters/Victoria Klesty ...

Novo Nordisk has made its smart insulin pens available in the UK ... According to Novo Nordisk, people living with type 1 (insulin-dependent) diabetes saw a reduction in time spent in ...

Novo Nordisk is providing direct-to-patient delivery ... Wegovy, a glucagon-like peptide-1 (GLP-1) receptor agonist, is indicated in combination with a reduced calorie diet and increased physical ...

He also revealed that the company will explore how GLP-1 drugs could help patients struggling with addiction. Ludovic Helfgott, Executive Vice President, Rare Disease, Novo Nordisk revealed that ...

Novo Nordisk ... high-quality pen.” In the release detailing the launch of NovoCare, the drugmaker acknowledged the prominence of compounded pharmacies and telehealth companies offering compounded ...

It has been estimated that 90% of medical device waste consists of single-use products or components, so a new initiative by Novo Nordisk to recycle pre-filled injection pens used by people living ...